Region-specific inhibition of potassium-evoked [3H]noradrenaline release from rat brain synaptosomes by neuropeptide Y-(13-36). Involvement of NPY receptors of the Y2 type

Eur J Pharmacol. 1993 Jan 12;230(2):231-4. doi: 10.1016/0014-2999(93)90807-t.

Abstract

The effects of the Y2 receptor agonist neuropeptide Y NPY-(13-36) on the depolarization-evoked release of [3H]noradrenaline (NA) from synaptosomal preparations of the medulla oblongata, the hypothalamus, the hippocampal formation and the parieto-occipital cortex of the male rat were studied. NPY-(13-36) (0.1-100 nM) caused a concentration-related inhibition of the depolarization-induced release of [3H]NA in all areas studied, except the parieto-occipital cortex. The results indicate that NPY Y2 receptors are present on NA terminals in all areas studied, except the parieto-occipital cortex and inhibit depolarization-evoked [3H]NA release.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain / drug effects*
  • Brain / metabolism
  • Male
  • Neuropeptide Y / pharmacology*
  • Norepinephrine / metabolism*
  • Peptide Fragments / pharmacology*
  • Phentolamine / pharmacology
  • Potassium / antagonists & inhibitors*
  • Rats
  • Rats, Wistar
  • Receptors, Neuropeptide Y / drug effects*
  • Synaptosomes / drug effects*
  • Synaptosomes / metabolism

Substances

  • Neuropeptide Y
  • Peptide Fragments
  • Receptors, Neuropeptide Y
  • neuropeptide Y (13-36)
  • Potassium
  • Norepinephrine
  • Phentolamine